Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 49Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Burkitt Lymphoma 12Lymphoma, Mantle-Cell 6Recurrence 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myeloid, Acute 5Neoplasm Metastasis 4Leukemia 4Immunoglobulin Light-chain Amyloidosis 4Breast Neoplasms 4Blast Crisis 4Vomiting 3Smoldering Multiple Myeloma 3Myelodysplastic Syndromes 3Lymphoma 3Leukemia, Myelomonocytic, Chronic 3Hodgkin Disease 3Hematologic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Plasmacytoma 2Ovarian Neoplasms 2Neoplasms, Plasma Cell 2Neoplasms 2Nausea 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2

Interventions

olaparib 2tetracarboxyphenylporphine 1testosterone enanthate 1testosterone 17 beta-cypionate 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Testosterone Propionate 1Dexamethasone 1Cyclophosphamide 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Castration-Resistant Prostate Carcinoma × dexamethasone 21-phosphate × Clear all
NCT05479578 2025-01-08

Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer

University of California, Davis

Phase 1 Active not recruiting
7 enrolled
Genitourinary

Castration-Resistant Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡